Professor William Hwang
Senior Advisor, Singapore Health Services
Professor William Hwang is Co-Director of the Regenerative Medicine Institute of Singapore (REMEDIS) and a Senior Consultant, Department of Haematology at National Cancer Centre Singapore (NCCS) and Singapore General Hospital (SGH). He previously served as the Chief Executive Officer of NCCS and is currently Senior Advisor, SingHealth, to the SingHealth Board of Advisors. As the founding Medical Director of the Singapore Cord Blood Bank, Singapore’s first public cord blood bank, Prof Hwang also initiated and set up the SingHealth Duke-NUS Cell Therapy Centre and REMEDIS as a joint institute of SingHealth Duke-NUS Academic Medical Centre.
Prof Hwang is currently Deputy Chairman of Ministry of Health’s (MOH) Clinical Services Strategy Committee for Cell Therapy, and also on the Board Oversight Committee of two entities in MOH Holdings – the Singapore Translational Cancer Consortium, and ACTRIS. He currently serves as Chairman of the Lien Centre for Palliative Care and Co-Chair of the National Advisory Committee on Cancer Care. He is also Chair of the Biobanking Advisory, MOH; Co-Chair of the Cell, Tissue and Gene Therapy Regulations workgroup, and Co-Chair of the HSCT Regulations workgroup.
He was previously President of the World Marrow Donor Association and an Executive Board member of the Asia Pacific Blood and Marrow Transplant Group. He currently serves as a Global Committee member of the European Blood and Marrow Transplant Group and Regional Vice-President (Asia) of the International Society of Cell and Gene Therapy.
A recipient of the National Outstanding Clinician Award at the National Medical Excellence Awards 2023, Prof Hwang has published over 140 scientific papers, and conducted clinical trials and laboratory research in haematology.